methotrimeprazine has been researched along with Down Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
| BRAUNER, F | 1 |
1 review(s) available for methotrimeprazine and Down Syndrome
| Article | Year |
|---|---|
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
1 other study(ies) available for methotrimeprazine and Down Syndrome
| Article | Year |
|---|---|
[OBSERVATIONS ON THE TOLERANCE TO NEUROLEPTICS IN MENTALLY DEFICIENT CHILDREN IN A SEMI-OPEN MILIEU].
Topics: Antipsychotic Agents; Catecholamines; Child; Down Syndrome; Haloperidol; Humans; Intellectual Disability; Metabolism; Methotrimeprazine; Persons with Mental Disabilities; Phenothiazines; Serotonin; Toxicology; Tranquilizing Agents; Tryptophan | 1964 |